← Back
$RCKT All transactions

ROCKET PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

383,854

Price

$0

Filed

Oct 8

Insider

Name

Rizvi Syed Ali-aamir

Title

Chief Medical Officer

CIK

0001897621

Roles

Officer

Transaction Details

Transaction Date

2025-10-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

383,854

Footnotes

Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. | Represents RSUs that will vest in two installments. One-half (1/2) of the RSUs will become fully vested on October 6, 2026 and the remaining RSUs will vest on the second anniversary of the grant date, such that all of the shares underlying the award will be vested on the date two (2) years after the grant date, subject to the reporting person's continued employment with the Issuer or any of its subsidiaries. | Represents non-qualified stock options ("NQSOs") that convert to common stock on a one-for-one basis. One-third (1/3) of such NQSOs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Filing Info

Accession No.

0001140361-25-037683

Form Type

4

Issuer CIK

0001281895

Rizvi Syed Ali-aamir's History

Date Ticker Type Value
2025-10-06 RCKT A $0
2025-10-06 RCKT A $0
2025-10-06 RCKT A $0

Other Insiders at RCKT (90d)

No other insider activity at this issuer in the last 90 days.